News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Devax, Inc. Initiates First Drug-Coated Stent Clinical Trial For A Dedicated Bifurcated Coronary Stent System


10/19/2005 5:08:51 PM

Devax Inc. announced today the initiation of the AXXESS(TM) PLUS Clinical Study for the company's AXXESS Drug-Coated Stent System ("AXXESS Stent System"). The AXXESS Stent System is the first bifurcated stent design to elute an anti-restenonic drug. The AXXESS PLUS Clinical Study is a multi-center trial to evaluate both the acute and long-term clinical utility of the AXXESS Stent System for the treatment of bifurcated lesions in native coronary arteries.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES